Drug Firms Under Suspicion

Investigative actions in a number of large pharmaceutical companies in Moscow are part of a criminal investigation into suspected violations of the anti-monopoly legislation, a law enforcement source said.

The case was initiated by the Federal Anti-Monopoly Service on charges of preventing, restricting or removing competition.

"Over 150 contracts totaling more than 66 billion rubles are being checked," the source said. Earlier, police sources reported the confiscation of documents at the Valenta, Akrikhin, Teva and Novartis pharmaceutical firms.

(Interfax)

Read more